Measuring Value of an IDN Specialty Pharmacy Therapy Management Program for Biologics

ACPE UAN #:  0233-0000-19-038-H04-P

Release Date:  March 27, 2019

Expiration Date:   March 27, 2022

Activity Type:    Knowledge-based

Contact Hours:  1.25 contact hours

Activity Fee:  Member:  $15        Non-Member: $30

Target Audience: Pharmacists who practice in managed care settings.

Activity Overview

As pharmacy costs continue to rise, alternative forms of care management are being implemented in an attempt to contain costs. Specialty pharmacy groups within integrated delivery networks (IDNs) are implementing therapy management programs to improve both outcomes and health care costs. This session will describe the collaborative process, and results of measuring predictors of adherence, persistence and improved clinical outcomes in patients with immunological disorders being treated with biologics. The session will also highlight challenges and solutions in implementing studies in the highly regulated and demanding health care environment, addressing such issues as legal considerations, sharing confidential information, ownership of data and results, accessing critical data, and identifying internal champions.

Join this session to discover lessons learned and best practices managed care organizations and health systems can use to gain analytic insights, bridge knowledge gaps, apply results to practice, and advance health care.

Learning Objectives:

At the completion of this activity, participants should be able to:

  1.  Explain considerations related to the measurement of impact and outcomes of health care delivery through collaborative research partnerships with integrated delivery networks (IDNs).
  2.  Identify opportunities for outcomes research between health systems and pharmaceutical manufacturers that use real-world evidence.
  3.  Discuss best practices and lessons learned from collaborative research projects.
  4.  Summarize evidence demonstrating how specialty pharmacy therapy management programs improve adherence and persistence to biologic treatments.

Schedule of Educational Activity

This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation. 

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2019.

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

 To receive credit for an online activity you must:

  •  Review the full content of the activity.
  •  Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  •  Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

Moderator:

Kevin Lu, PhD, BSPharm | Associate Professor | University of South Carolina | Columbia, South Carolina

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-19-038-H04-P 1.25 Contact Hours March 27, 2019 - March 27, 2022